• SENSEX 74,151.04
    905.01 (+1.24%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • NSE
    1,795.00 1,878.00(%)
  • Tube Investments
    2,177.45 3,335.00(%)
  • PTC Industries
    24,888.20 26,049.95(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • HDFC Bank
    678.05 668.90(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,203.00 2,050.25(%)
  • Cholaman.Inv.&Fn
    1,618.00 1,952.00(%)
  • Bharti Airtel
    1,977.75 2,174.70(%)
  • Birlasoft Ltd
    352.25 473.75(%)
  • ICICI Bank
    1,387.55 1,479.90(%)
  • Billionbrains
    193.00 227.00(%)
  • Bajaj Finance
    943.00 1,177.60(%)
  • SBI
    980.00 1,234.80(%)
  • Adani Ports
    1,872.20 1,891.80(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • Kotak Mah. Bank
    460.00 453.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ANG Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70392.0
  • ISIN : INE236W01016
33.50 0 (0.36%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    33.50

  • Today’s High

    38.48

  • Open

    34.38

  • Perv Close

    33.38

  • 52W Low

    17.63

  • 52W High

    49.69

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    43.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    47.37

  • Debt-Equity Ratio

    0.36

  • AGM Date

    28-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.88

  • Mar.Cap (₹Cr.)

    43.75

  • RONW (%)

    -10.56

  • ROCE (%)

    1.43

Score Board

  • Equity (₹ in Cr.)

    13.06

  • BV (₹)

    47.40

  • Sales( ₹ in Cr.)

    91.60

  • NP (in Cr.)

    -4.76

  • NP Var(%)

    52.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    -3.60

  • Traded Value (₹ in Lakhs)

    43.75

  • 52 Week High

    49.69

  • 52 Week Low

    17.63

  • Price BSE

    34.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    43.75

  • P/C Ratio

    33.50

  • P/E Ratio

    -9.30

  • Price Vs.BV

    -3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 91.60 89.91 131.37 207.01 348.67 154.28
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 91.60 89.91 131.37 207.01 348.67 154.28
Other Income 0.73 2.44 0.84 9.84 0.95 0.75
Stock Adjustments -3.21 3.39 6.74 4.22 4.47 4.30
Total Income 89.12 95.74 138.95 221.07 354.09 159.33
EXPENDITURE :            
Raw Materials 55.08 63.98 93.93 151.12 234.49 108.26
Power and Fuel Cost 3.67 3.25 3.61 5.99 5.68 4.88
Employee Cost 14.35 14.45 15.90 20.27 18.32 14.35
Other Manufacturing Expenses 1.43 1.36 0.91 1.85 2.96 1.60
Selling and Administration Expenses 5.93 10.63 13.04 18.21 23.49 13.56
Miscellaneous Expenses 1.02 1.10 2.89 2.12 2.65 0.59
Employee Benefit Expenses 14.35 14.45 15.90 20.27 18.32 14.35
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 81.49 94.77 130.28 199.56 287.60 143.24
Operating Profit 7.63 0.97 8.66 21.51 66.49 16.08
Interest 6.74 7.64 9.77 10.92 8.31 3.98
Gross Profit 0.89 -6.67 -1.11 10.59 58.18 12.10
Depreciation 6.08 6.27 7.75 8.52 5.12 2.24
Profit Before Tax -5.19 -12.94 -8.86 2.07 53.06 9.86
Current Tax 0.00 0.00 0.00 2.11 13.47 3.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.46 -2.59 -0.22 0.62 -0.11 -0.57
Reported Net Profit -4.73 -10.34 -8.65 -0.66 39.71 7.25
Extraordinary Items 0.03 -0.45 -1.56 -0.27 0.00 0.00
Adjusted Net Profit -4.76 -9.89 -7.09 -0.39 39.71 7.25
Adjustment below Net Profit 0.13 0.08 0.19 0.72 0.21 -0.70
P & L Balance brought forward 48.76 59.02 63.16 63.10 24.22 17.67
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 -4.33 0.00 1.04 0.00
P & L Balance carried down 44.17 48.76 59.02 63.16 63.10 24.22
Dividend 0.00 0.00 0.00 0.00 1.04 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 10.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 1.00 0.00
Earnings Per Share-Unit Curr -3.62 -7.92 -6.62 -0.51 38.31 13.99
Earnings Per Share(Adj)-Unit Curr -3.62 -7.92 -6.62 -0.51 30.65 5.60
Book Value 47.37 50.88 58.74 61.91 76.00 76.99
Book Value(Adj)-Unit Curr 47.37 50.88 58.74 61.91 60.80 30.80

Shareholding Pattern

  • Promoter Group

    70.60%

  • Public Share Holding

    29.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,219,537 70.60 9,219,537 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,219,537 70.60 9,219,537 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 25,622 0.20 25,622 20
Clearing Members 10,471 0.08 10,471 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 249,073 1.91 249,073 68
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 101,248 0.78 101,248 78
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,018,921 7.80 1,018,921 22
Individuals holding nominal share capital up to Rs. 1 lakh 2,431,248 18.62 2,426,698 5,472
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,167 0.02 2,167 1
Sub Total 3,838,750 29.40 3,834,200 5,664
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,058,287 100.00 13,053,737 5,666

Company Background

ANG Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • ANG Lifesciences India Ltd
  • BSE Code : 70392.0
  • ISIN : INE236W01016

  • Incorporation Year

    2006

  • Registered Office

    Darbara Complex SCO 113 I Flr
    Dist. Shopping Centre B Block, Amritsar,
    Punjab-143001

  • Telephone

    91-0183-5070118/5070119

  • FAX

  • Chairman

  • Managing Director

    Rajesh Gupta

  • Company Secretary

    Harshita Aggarwal

  • Auditor

    Khurana Sharma & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

ANG Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ANG Lifesciences 33.50 92.33 91.60 -5.95 1.15
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77